FindTrial
Sign In

Effect of autologous platelet-rich plasma on patients with acute type A aortic dissection

Effect of autologous platelet-rich plasma on patients with acute type A aortic dissection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070712
Enrollment
Unknown
Registered
2023-04-20
Start date
2023-04-20
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aortic dissection

Interventions

PRP group (PRP treatment during operation):N/A
Non PRP group (no PRP treatment during operation):N/A

Sponsors

The Second Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Type A aortic dissection was diagnosed. 2. Aortic arch replacement has been performed.

Exclusion criteria

Exclusion criteria: 1. Weight80 years old; ASA =V 2.SvO2<75%; Systolic blood pressure<90 mmHg; Central venous pressure<10cmH2O 3.stroke; end-stage renal disease 4. Hemoglobin<10g/dL or hematocrit<30%; blood coagulation disorders.

Design outcomes

Primary

MeasureTime frame
Transfusion volume;CTA;Blood routine;Liver and kidney function;Coagulation function;Cardiac ultrasound;—

Secondary

MeasureTime frame
age;gender;BMI;Surgical method;Parameters of cardiopulmonary bypass;—

Countries

China

Contacts

Public ContactYaping Wang

The Second Xiangya Hospital of Central South University

wangyaping6568@126.com+86 13607314476

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026